Table of Contents Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs 1.1 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Overview 1.1.1 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Scope 1.1.2 Market Status and Outlook 1.2 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market by Type 1.3.1 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million US$) and Growth Comparison by Type (2014-2025) 1.3.2 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share by Type in 2018 1.3.3 Macular Degeneration Drugs 1.3.4 Diabetic Retinopathy Drugs 1.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market by End Users/Application 1.4.1 50-60 Years Old 1.4.2 60-70 Years Old 1.4.3 Other 2 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Competition Analysis by Players 2.1 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million US$) by Players (2014-2019) 2.2 Competitive Status 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 Mergers & Acquisitions, Expansion Plans 3 Company (Top Players) Profiles and Key Data 3.1 Novartis 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Bayer Healthcare 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 Roche 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Neurotech Pharmaceuticals 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Regeneron Pharmaceuticals 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 Allergan 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Value) (2014-2019) 3.6.5 Recent Developments ... 4 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type and Application (2014-2019) 4.1 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type (2014-2019) 4.2 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) 4.3 Potential Application of Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in Future 4.4 Top Consumer/End Users of Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs 5 North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Development Status and Outlook 5.1 North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2014-2019) 5.2 North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Market Share by Players (2014-2019) 5.3 North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) 6 Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Development Status and Outlook 6.1 Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2014-2019) 6.2 Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Market Share by Players (2014-2019) 6.3 Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) 7 China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Development Status and Outlook 7.1 China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2014-2019) 7.2 China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Market Share by Players (2014-2019) 7.3 China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) 8 Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Development Status and Outlook 8.1 Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2014-2019) 8.2 Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Market Share by Players (2014-2019) 8.3 Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) 9 Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Development Status and Outlook 9.1 Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2014-2019) 9.2 Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Market Share by Players (2014-2019) 9.3 Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) 10 Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Development Status and Outlook 10.1 Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (2014-2019) 10.2 Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Market Share by Players (2014-2019) 10.3 Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) 11 Market Forecast by Regions and Application (2019-2025) 11.1 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Regions (2019-2025) 11.1.1 North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue and Growth Rate (2019-2025) 11.1.2 Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue and Growth Rate (2019-2025) 11.1.3 China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue and Growth Rate (2019-2025) 11.2 Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2019-2025) 11.3 The Market Drivers in Future 12 Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Dynamics 12.1 Industry Trends 12.2 Market Drivers 12.3 Market Challenges 12.4 Porter’s Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables and Figures Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) Status and Outlook (2014-2025) Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2025) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Regions (2014-2019) Figure North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Type in 2018 & 2025 Figure Macular Degeneration Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Diabetic Retinopathy Drugs Market Size (Million USD) and Growth Rate (2014-2019) Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million US$) Comparison by Application (2014-2025) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Application in 2018 & 2025 Figure Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate in 50-60 Years Old (2014-2019) Figure Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate in 60-70 Years Old (2014-2019) Figure Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million USD) and Growth Rate in Other (2014-2019) Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million US$) by Players (2014-2019) Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share by Players (2014-2019) Eigure Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Global Top 5 Players Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share in 2018 Figure Global Top 10 Players Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share in 2018 Table Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Key Players Product/Service Table Mergers & Acquisitions, Expansion Plans Table Novartis Basic Information List Table Novartis Description and Business Overview Table Novartis Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products, Services and Solutions Table Revenue (Million US$) in Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business of Novartis (2014-2019) Table Novartis Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Recent Developments Table Bayer Healthcare Basic Information List Table Bayer Healthcare Description and Business Overview Table Bayer Healthcare Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products, Services and Solutions Table Revenue (Million US$) in Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business of Bayer Healthcare (2014-2019) Table Bayer Healthcare Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Recent Developments Table Roche Basic Information List Table Roche Description and Business Overview Table Roche Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products, Services and Solutions Table Revenue (Million US$) in Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business of Roche (2014-2019) Table Roche Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Recent Developments Table Neurotech Pharmaceuticals Basic Information List Table Neurotech Pharmaceuticals Description and Business Overview Table Neurotech Pharmaceuticals Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products, Services and Solutions Table Revenue (Million US$) in Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business of Neurotech Pharmaceuticals (2014-2019) Table Neurotech Pharmaceuticals Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Recent Developments Table Regeneron Pharmaceuticals Basic Information List Table Regeneron Pharmaceuticals Description and Business Overview Table Regeneron Pharmaceuticals Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products, Services and Solutions Table Revenue (Million US$) in Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business of Regeneron Pharmaceuticals (2014-2019) Table Regeneron Pharmaceuticals Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Recent Developments Table Allergan Basic Information List Table Allergan Description and Business Overview Table Allergan Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products, Services and Solutions Table Revenue (Million US$) in Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business of Allergan (2014-2019) Table Allergan Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Recent Developments Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type (2014-2019) (Million US$) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share by Type in 2018 Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) (Million US$) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market by Application in 2018 Table Top Consumer/End Users of Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Figure North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Players (2014-2019)(Million US$) Figure North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Table North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) (Million US$) Figure North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share by Application (2014-2019) Figure North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Application in 2018 Figure Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Players (2014-2019)(Million US$) Figure Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Table Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) (Million US$) Figure Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share by Application (2014-2019) Figure Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Application in 2018 Figure China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Players (2014-2019)(Million US$) Figure China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Table China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) (Million US$) Figure China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share by Application (2014-2019) Figure China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Application in 2018 Figure Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Players (2014-2019)(Million US$) Figure Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Table Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) (Million US$) Figure Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share by Application (2014-2019) Figure Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Application in 2018 Figure Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Players (2014-2019)(Million US$) Figure Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Table Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) (Million US$) Figure Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share by Application (2014-2019) Figure Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Application in 2018 Figure Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Growth Rate(2014-2019) (Million USD) Table Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Players (2014-2019)(Million US$) Figure Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Players in 2018 Table Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2014-2019) (Million US$) Figure Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Market Share by Application (2014-2019) Figure Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Application in 2018 Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and Growth Rate (Value) (2019-2025) (Million US$) Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Regions (2019-2025) (Million US$) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Regions (2019-2025) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Share by Regions in 2025 Figure North America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure China Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (Million USD) and Growth Rate (2019-2025) Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2019-2025) (Million USD) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application (2019-2025) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application in 2025 Table Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type (2019-2025) (Million US$) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type (2019-2025) Figure Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type in 2025 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure Porter's Five Forces Analysis Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Novartis Bayer Healthcare Roche Neurotech Pharmaceuticals Regeneron Pharmaceuticals Allergan